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Abstract 
Introduction 
Functional movement disorders are accompanied by a high occurrence of psychopathology 
and cause serious impairments in quality of life. However, little is known about this in 
patients with functional jerks and no comparison has been made between patients with 
functional jerks and organic myoclonus. This case control study compares the occurrence of 
depression, anxiety and quality of life (HR-QoL) in patients with functional jerks and cortical 
myoclonus. 
Methods 
Patients with functional jerks and cortical myoclonus, consecutively recruited, were compared 
on self-rated anxiety (Beck Anxiety Inventory), depression (Beck Depression Inventory), 
health-related quality of life (RAND-36), and myoclonus severity (UMRS and CGI-S rating 
scales). 
Results 
Sixteen patients with functional jerks and 23 with cortical myoclonus were evaluated. There 
was no significant difference in depression (44% vs. 43%) or anxiety (44% vs. 47%) scores 
between groups. The HR-QoL was similarly impaired except that functional jerks patients 
reported significantly more pain (p < 0.05). Only in the functional jerks group myoclonus 
severity correlated with depression and anxiety. 
Conclusion 
Depression and anxiety scores are high and do not discriminate between functional jerks and 
cortical myoclonus. Quality of life was equally impaired in both sub-groups, but pain was 
significantly worse in patients with functional jerks.  
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Introduction 
Functional movement disorders (FMD) are disabling involuntary movements, which can be 
defined by incongruence with known neurological pathology and the influence maneuvers 
like distraction and suggestion. One of the manifestations of FMD is functional jerks 
(myoclonus) (FJ), which has a prevalence amongst FMD of approximately 15% [1]. 
FJ is characterized by an acute onset of jerks with a slow or variable burst duration, an 
inconsistent distribution, and reduction with distraction [2]. Clinical discrimination between 
FJ and organic myoclonus can be very difficult, even for world class experts [3]. In these 
cases, electrophysiological testing aids in the diagnosis of FJ, especially with the finding of a 
pre-movement or Bereitschaftspotential with back-averaging. Accurate and early diagnosing 
of FJ is important as prompt treatment improves patient’s outcome [4]. There is no evidence 
on specific therapy for FJ, but patient education and specialized physiotherapy are considered 
increasingly important in the treatment of FMD [5].  
Symptoms of depression and anxiety are more common in FMD than in healthy controls, with 
37,1%-61% lifetime depression and 20% - 21% generalised anxiety disorder in two key 
publications [6]. Although psychopathology has been found to be high in FMD [7], this is not 
unique for FMD as organic movement disorders are also often accompanied by 
psychopathology [8-10]. Studies comparing FMD with organic neurological disorders found 
either more affective disorders and anxiety in FMD, or equal prevalences [6]. Furthermore, 
previous studies reported a similar level of impairment of the quality of life and daily 
functioning, for example when comparing FMD with Parkinson’s Disease [7,11]. In multiple 
movement disorders there is an ongoing discussion whether psychiatric co-morbidity are 
primary and part of the phenotype or a secondary consequence of the motor disorder [8,12]. 
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Little is known about the psychiatric co-morbidity in patients with FJ, and, to date, there has 
been no systematic comparison with an appropriate control group. In our study we explored 
the depression and anxiety rate, and whether these psychiatric symptoms and the perceived 
health related quality of life could discriminate between FJ and cortical myoclonus (CM). 
Based on the literature, our hypothesis is that patients with FJ experience more symptoms of 
depression, anxiety, and have a greater impairment of their quality of life. 
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Methods 
Recruitment 
Adult patients with FJ and CM were consecutively recruited from both the outpatient clinic 
and the ward of the Neurology department of our tertiary referral centre between May 2014 
and June 2016. Patients were excluded if they were aged less than 16, or were judged to have 
significant cognitive impairment interfering with ability to complete measures. In all patients 
a comprehensive history was taken, including age at onset, co-existing neurological 
symptoms, and non-neurological co-morbidity. All subjects previously participated in a study 
about the value of electrophysiological testing in determination of the myoclonus subtype 
(article under review).  
The Ethical Board of the University Medical Center Groningen (UMCG) approved the study 
(Number M14.157933). 
Motor assessment 
All patients underwent a medical history, protocolled videotaped clinical examination and 
electrophysiological testing. The diagnosis CM or FJ was made by a movement disorder 
specialist (MT) based on clinical characteristics. Co-existing neurological symptoms 
including additional movement disorders were recorded.  
Severity of myoclonus was scored by two independent experts using the modified versions of 
the Unified Myoclonus Rating Scale (UMRS) [13] and the 7 point Global Clinical Impression 
– Severity (GCI-S) scale [14]. The average score of the two experts was used. 
Psychiatric and quality of life assessment 
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Participants were asked to fill out a questionnaire consisting of the Beck anxiety Inventory 
(BAI) [15], and the Beck depression inventory (BDI) [16]. For the BDI, we used a cut-off 
score of 10 or higher to distinguish depressive from non-depressive patients, the range for 
mild depression was 10-19, moderate 19-29 and severe 30-63 [16]. For the BAI the same 
scores were used to divide symptoms into no, mild, moderate and severe anxiety [17]. Three 
items on the BAI concerning trembling or shaking of several body parts were excluded from 
analysis, without adjustment of the marking of the BAI, as these questions are inherent to the 
movement disorders studied.  The RAND 36 questionnaire, a Dutch validated version of the 
SF36 was used for measuring quality of life [18].  
 
Statistical analysis 
Chi-square tests were used for categorical variables and Mann-Whitney U tests for ordinal 
and continuous not-normally distributed data in SPSS 23. When differences between groups 
were found, odds ratios were calculated using binominal logistic regression analysis, to 
provide predictive value of the factor for being in one of the groups. Inter-rater reliability for 
video motor scoring was assessed using the intra-class correlation coefficient (ICC) (Two way 
mixed, consistency, average measures). Correlations between physical functioning (RAND-36 
subscale), depression (BDI), anxiety (BAI) and symptom severity (CGI), were calculated 
using Spearman’s correlation in both groups. No violations were noted of the completed 
statistical analyses. All statistical tests were two-sided. The p-values of <0.05 were considered 
as statistically significant. 
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Results 
Participants characteristics 
Forty-seven adult patients, including 27 with CM and 20 FJ were recruited. Three CM cases 
were excluded from the study due to cognitive problems and five cases (4FJ and 1CM) had 
not completed the questionnaires.  
In total 39 patients; 16 FJ (69% female, median age at examination 32 years) and 23 CM 
patients (52% female, median age at examination 30 years) participated in the study. 
The severity of myoclonus on the UMRS was significantly higher for FJ (FJ:16.5, CM: 5.7) 
without a significant difference in CGI-S (FJ:4, CM:3) with a good ICC between raters  (ICC 
UMRS = 0.98 (95% CI: 0.95-0.99) / ICC GCI-S = 0.82 (95% CI: 0.67- 0.91)). 
Co-existing neurological symptoms were detected in five of the 20 FJ and in nine of the 27 
CM patients (Table 1).  
In the CM group, in 15/23 cases an aetiological diagnosis was made; five had an acquired 
cause, 10 cases were thought to have a genetic origin of which a causative gene mutation was 
found in seven cases (see Supplementary Table 1). 
The demographic features are shown in Table 1. 
Occurrence of depression, anxiety, and health related quality of life 
As is shown in Table 1, in the FJ group, 7/16 (44%) met criteria for a mild to severe 
depression and in the CM group this was 10/23 (43%). The median depression score on the 
BDI was not significantly different between the FJ and CM groups (FJ: 7 (0-43), CM: 9 (0-
25), p=0.72).  
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Seven of 16 (44%) FJ patients and 11/23 (48%) CM patients met criteria for mild to severe 
anxiety. The median BAI score was not significantly different for FJ (6 (0-28)) compared to 
CM patients (7 (0-26)).  
On all subdomains of HR-QoL FJ and CM patients were equally impaired, except for the 
subdomain of pain. FJ patients reported significantly more pain (FJ vs CM median 49 (IQR 
52) vs median 80 (IQR 33), p < 0.05). Details about HR-QoL subdomains and severity of 
depression and anxiety can be found in Table 1. 
As is shown in Table 2, myoclonus severity was correlated to both depression and anxiety in 
the FJ group, but not in the CM group. Pain was correlated to physical functioning in CM but 
not in FJ.  
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Discussion   
 
In this prospective study, we showed functional jerks and cortical myoclonus patients had 
equally high depression and anxiety scores and a similar impaired health related quality of 
life. Patients with FJ reported significantly more pain compared to the CM group.  
The occurrence of mild to severe depression and anxiety in both FJ and CM found in our 
cohort is high compared to the normal population. In FJ, this confirms earlier findings in 
several types of functional neurological disorders [7]. Psychiatric co-morbidity in a 
heterogeneous group of CM has not been studied before, but our results are comparable with 
the rates of anxiety and depression reported in CM patients diagnosed with Familial Cortical 
Myoclonic Tremor and Epilepsy and Juvenile Myoclonus Epilepsy [19,20]. These findings 
might implicate that cortical myoclonus syndromes in general are associated with psychiatric 
co-morbidity. In myoclonus dystonia (M-D) psychiatric comorbidity has consistently been 
described [10]. However, as M-D has a subcortical anatomical origin rather than cortical, a 
direct comparison with CM cannot be made. All in all, the similar levels of depression and 
anxiety in FJ and CM underline current views that these symptoms are not diagnostically 
relevant for FJ. The findings do, however, emphasize the importance for treatment of looking 
for anxiety and depression in both patient groups [5]. 
Health related quality of life was similarly impaired in FJ and CM patients, as was 
hypothesized based on the literature [7,11]. Pain was the only HRQoL subdomain 
significantly higher in the FJ group (median 49 (IQR 52) vs median 80 (IQR 33), p< 0.05). 
Pain has been reported to be high in other subtypes of FMD, mainly functional (fixed) 
dystonia [21]. The relation between FJ and pain has not been studied before. Our finding 
implies that pain might be a promising diagnostic tool to discriminate FJ from other jerky 
movements, but this requires further studies in a larger prospective cohort. 
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Myoclonus severity was found to correlate with anxiety and depression scores in FJ but not 
CM. This might suggest that in the FJ group, there is a bidirectional relationship between 
anxiety/depression and myoclonus. Previous studies have shown that chronic pain negatively 
influences mood and quality of life [22]. However, in our cohort pain did not explain the 
relationship between anxiety/depression and myoclonus, as pain was not correlated to 
myoclonus severity. The lack of a relationship between anxiety/depression and myoclonus in 
CM suggest that these symptoms could be part of the CM phenotype or could be caused by 
other factors not taken into account in this study. To be able to determine whether the 
psychiatric symptoms have a primary or secondary cause, larger, preferably longitudinal, 
studies are required.  
This study has limitations. As applies to all rare disorders, we had to study a small sample 
from a tertiary clinic, which improves diagnostic accuracy but might impair generalizability. 
Furthermore, using the BAI might have caused an overestimation of anxiety in both groups, 
as it largely measures the experience of physical complaints, which are partly influenced by 
having myoclonus. In order to minimize this overestimation, we have excluded questions 
directly related to jerky movements, while retaining the cut-off value.  
In conclusion, this study showed high depression and anxiety scores and a comparable 
impairment of the quality of life in patients with FJ and CM, with significantly more pain in 
the FJ group. It is important for clinicians to be aware of the high appearance of depression 
and anxiety in myoclonic disorders as these symptoms often require treatment. Unfortunately, 
the presence of depression and anxiety cannot be used as a diagnostic tool for FJ, however, 
pain might be a significant marker of differentiation between organic myoclonus and 
functional jerks.  
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Table 1: Demographic features, psychiatric co-morbidity and quality of life in functional 
jerks versus cortical mycolonus patients 
 
 CM (n=23) FJ (n=16) 
Female  N (%) 12 (52%) 11 (69%) 
Age at examination, median (IQR) 30 (32) 32 (38) 
Age at onset of myoclonus, median (IQR) 17 (39) 25 (36) 
Total UMRS, median (IQR) 5,7 (15) 16,5 (14)* 
Total GCI-S, median (IQR) 3 (4) 4 (4) 
Medical history    
epilepsy 
 
5 0 
cognitive problems 
 
4 0 
structural brain damage 
 
3 1 
Other neurological symptoms 
  
dystonia  5 0 
ataxia  4 0 
spasticity 
 
0 1 
other functional symptoms 
 
0 4 
Median RAND-36 scores (IQR) 
  
Physical functioning 60 (56) 75 (63) 
Social functioning 63 (38) 63 (59) 
Role limitation physical 50( 100) 12,5 (94) 
Role limitation emotional 100 (100) 100 (50) 
Mental health 76 (32) 78 (20) 
Vitality 50 (30) 50 (30) 
Pain 80 (33) 49 (52)* 
General health perception 40 (15) 50 (35) 
Expected health change 50 (25) 50 (50) 
Median BDI (range) (cut-off scores) 9 (0 - 25) 7 (0 - 43) 
No depression (0-9) 13 9 
Mild depression (10-18) 7 4 
Moderate depression (19-29) 3 1 
Severe depression (30-63) 0 2 
Median BAI (range) 7 (0 - 26) 7 (3 - 28) 
No anxiety (0-9) 
 
12 9 
Mild anxiety (10-18)  
 
7 4 
Moderate anxiety (19-29) 
 
4 3 
Severe anxiety (30-63) 
 
0 0 
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Table 2: Correlations between myoclonus severity, psychiatric co-morbidity and HR-
QoL 
 
 Physical functioning (RAND36) Myoclonus severity (mean CGI-S) 
 Functional jerks 
(FJ) 
Cortical 
myoclonus (CM) 
Functional jerks 
(FJ) 
Cortical 
myoclonus (CM) 
Myoclonus severity (mean CGI-S) Rho -0,08 
P=0.77 
Rho -0,11 
P=0.61 
X X 
Depression (BDI) Rho -0,27 
P=0.33 
Rho -0.12 
P=0.60 
Rho 0.49,  
p = 0.05 
Rho 0.18,  
p = 0.42 
Anxiety (BAI -corrected) Rho -0,03 
P=0,91 
Rho -0.02 
P=0.91 
Rho 0.73,  
p <0.05 
Rho 0.36,  
p = 0.09 
Pain (RAND36) Rho 0.40 
P=0,12 
Rho 0.47 
p <0.05 
Rho -0,25 
P=0,34 
Rho 0,31 
P=0,14 
 
 
Legend Table 2: 
BAI: Beck Anxiety Inventory, BDI: Beck Depression Inventory, CGI-S: Global Clinical 
Impression – Severity, CM: cortical myoclonus, FJ: functional jerks. 
Statistically significant correlations using Spearman’s Rho (p<0.05) are highlighted in bold. 
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Highlights 
• High rates of depression and anxiety in FJ and CM 
• Depression and anxiety do not discriminate between FJ and CM 
• Health related quality of life is equally impaired in FJ and CM 
• FJ patients experience significantly more pain than CM patients 
 
 
